B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Lenvatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Lenvatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

osi
21 shared targets
tivozanib
17 shared targets
brivanib
17 shared targets
lucitanib
11 shared targets
regorafenib
15 shared targets
cabozantinib
14 shared targets
aee
13 shared targets
cep
14 shared targets
cediranib
23 shared targets
motesanib
15 shared targets
Loading evidence profile...

This evidence profile for Lenvatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.